Maze Therapeutics, Inc. (MAZE) Earnings
|
Expand Research on MAZE
| Next EPS Date | 8/18/26 | EPS Growth Rate | +26.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -0.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -12.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26  |
Q226 | N/A | -$0.57 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$0.45 | -$0.58 | +$0.13 | $20M | N/A | N/A |  | | Details | |
| 4/6/26 |
Q126 | N/A | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 | Q425 | -$0.65 | $0.00 | -$0.65 | N/A | N/A | N/A | | | Details | |
| 11/6/25 |
Q325 | N/A | -$0.62 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | -$0.77 | -$0.62 | -$0.15 | N/A | N/A | N/A | | | Details | |
| 5/15/25 |
Q125 | -$1.15 | N/A | N/A | N/A | N/A | N/A | | | Details |
